Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Development of a Bifunctional Checkpoint Inhibitory T Cell Engager (CiTE) to Reverse Adaptive Immune Escape in AML

Monika Herrmann, PhD, Christina Krupka, PhD, Katrin Deiser, PhD, Bettina Lindl, Ralph Mocikat, MD, Klaus H. Metzeler, MD, Karsten Spiekermann, MD, Sebastian Kobold, MD, Nadja Fenn, PhD, Karl-Peter Hopfner, PhD, Marion Subklewe, MD

Blood (2018) 132 (Supplement 1): 4069.

https://doi.org/10.1182/blood-2018-99-119624

Published: 2018

Journal Articles

Evaluation of a FLT3 Bite® for Acute Myeloid Leukemia

Rebecca Goldstein, PhD, Anja Henn, Priya Koppikar, PhD, Ivonne Archibeque, BA, Brendon Frank, Mercedesz Balazs, Christoph Dahlhoff, PhD, Tobias Raum, PhD, Chi-Ming Li, PhD, Joachim Wahl, PhD, Dan Rock, Oliver Thomas, BSc, Christine Karbowski, PhD, Christina Krupka, PhD, Marion Subklewe, MD, Angela Coxon, PhD, Tara Chapman-Arvedson

Blood (2017) 130 (Supplement 1): 1354.

https://doi.org/10.1182/blood.V130.Suppl_1.1354.1354

Published: 2017

Journal Articles

Identification of Novel Targets for Antibody or Chimeric Antigen Receptor (CAR) Based Immunotherapy in AML: Characterizing the Surfaceome from Primary Patient Samples

Thomas Koehnke, MD, Liu Xilong, Sascha Haubner, MD, Christina Krupka, PhD, Victor Solis-Mezarino, Franz Herzog, PhD, Wolfgang Hiddemann, MD PhD, Marion S. Subklewe, MD

Blood (2017) 130 (Supplement 1): 3968.

https://doi.org/10.1182/blood.V130.Suppl_1.3968.3968

Published: 2017

Journal Articles

Midostaurin Reduces Bite® Mediated Cytotoxicity Against Acute Myeloid Leukemia

Bettina Lindl, Christina Krupka, PhD, Tara Chapman-Arvedson, Roman Kischel, MD, Peter Kufer, MD, Sascha Haubner, MD, Felix S. Lichtenegger, MD, Thomas Koehnke, MD, Klaus H. Metzeler, MD, Nikola Konstandin, PhD, Karsten Spiekermann, Wolfgang Hiddemann, MD PhD, Marion Subklewe, MD

Blood (2017) 130 (Supplement 1): 2656.

https://doi.org/10.1182/blood.V130.Suppl_1.2656.2656

Published: 2017

Journal Articles

Induction of Antigen-Specific T-Cell Responses through Dendritic Cell Vaccination in AML: Results of a Phase I/II Trial and Ex Vivo Enhancement By Checkpoint Blockade

Felix S. Lichtenegger, MD, Katrin Deiser, PhD, Maurine Rothe, Frauke M. Schnorfeil, PhD, Christina Krupka, PhD, Christian Augsberger, Thomas Köhnke, MD, Veit L. Bücklein, MD, Torben Altmann, MD, Andreas Moosmann, Monika Brüggemann, MD PhD, Mirjam H.M. Heemskerk, PhD, Georg Wittmann, MD, Beate Wagner, MD, Wolfgang Hiddemann, MD, Iris Bigalke, PhD, Gunnar Kvalheim, MD PhD, Marion Subklewe, MD

Blood (2016) 128 (22): 764.

https://doi.org/10.1182/blood.V128.22.764.764

Published: 2016

NARROW

Development of a Bifunctional Checkpoint Inhibitory T Cell Engager (CiTE) to Reverse Adaptive Immune Escape in AML

Evaluation of a FLT3 Bite® for Acute Myeloid Leukemia

Identification of Novel Targets for Antibody or Chimeric Antigen Receptor (CAR) Based Immunotherapy in AML: Characterizing the Surfaceome from Primary Patient Samples

Midostaurin Reduces Bite® Mediated Cytotoxicity Against Acute Myeloid Leukemia

Induction of Antigen-Specific T-Cell Responses through Dendritic Cell Vaccination in AML: Results of a Phase I/II Trial and Ex Vivo Enhancement By Checkpoint Blockade

Email alerts

ASH Publications

American Society of Hematology

Development of a Bifunctional Checkpoint Inhibitory T Cell Engager (CiTE) to Reverse Adaptive Immune Escape in AML

Evaluation of a FLT3 Bite® for Acute Myeloid Leukemia

Identification of Novel Targets for Antibody or Chimeric Antigen Receptor (CAR) Based Immunotherapy in AML: Characterizing the Surfaceome from Primary Patient Samples

Midostaurin Reduces Bite® Mediated Cytotoxicity Against Acute Myeloid Leukemia

Induction of Antigen-Specific T-Cell Responses through Dendritic Cell Vaccination in AML: Results of a Phase I/II Trial and Ex Vivo Enhancement By Checkpoint Blockade

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only